REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Centro de Investigacion en Reumatologia y Especialidades Medicas Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Full name: Centro de Investigacion en Reumatologia y Especialidades Medicas Sas Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Centro de Investigacion En Reumatologia y Especialidades Medicas S.A.S. is primarily engaged in scientific research and development services.

Headquarters
Carrera 12 97 32 Oficina 201 Consultorio 201-1, 201-2 Oficina 301 Oficina 302 Consultorio 302-1, 302-2 Oficina 303 Consultorio 303-1, 303-2, 303-3 Oficina 403 Oficina 404 Deposito # 03
Bogota D.C.; Bogota D.C; Postal Code: 0810

Contact Details: Purchase the Centro de Investigacion en Reumatologia y Especialidades Medicas Sas report to view the information.

Basic Information
Total Employees:
Purchase the Centro de Investigacion en Reumatologia y Especialidades Medicas Sas report to view the information.
Outstanding Shares:
Purchase the Centro de Investigacion en Reumatologia y Especialidades Medicas Sas report to view the information.
Incorporation Date:
February 10, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Centro de Investigacion en Reumatologia y Especialidades Medicas Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
30.65%▲
Total operating revenue
30.65%▲
Operating profit (EBIT)
117.72%▲
EBITDA
107.54%▲
Net Profit (Loss) for the Period
102.03%▲
Total assets
32.29%▲
Total equity
43.86%▲
Operating Profit Margin (ROS)
6.61%▲
Net Profit Margin
3.5%▲
Return on Equity (ROE)
8.92%▲
Debt to Equity Ratio
-1.19%▼
Quick Ratio
0.87%▲
Cash Ratio
-0.09%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo